Clovis oncology stock quote
CLVS Stock Quote of Clovis Oncology Inc - InvestorPlace In recent Clovis Oncology news, CLVS stock is down close to 12% as the company's stopped its trial to treat bladder cancer, a report says. CLVS Clovis Oncology, Inc. Stock Quote - FINVIZ.com Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, the European Union, and internationally. Is Clovis Oncology Really a Buyout Candidate? | The Motley ... A legitimate buyout candidate vs. wishful thinking. Some might argue that Clovis Oncology is making progress where it matters. For instance, after reporting operating cash outflow of $98.4 million Clovis Oncology, Inc. - Investors & News - Events ...
Clovis Oncology, Inc. - TheStreet
Clovis Oncology, Inc. - Investors & News - Stock ... Stock Quote & Chart. Stock Chart. Investor Inquiries CLVS: Clovis Oncology Inc - Stock Price, Quote and News - CNBC Get Clovis Oncology Inc (CLVS:NASDAQ) real-time stock quotes, news and financial information from CNBC. CLVS - Stock quote for CLOVIS ONCOLOGY, INC. - MSN Money View the latest CLVS stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of CLOVIS ONCOLOGY, INC.. Clovis Oncology Inc. - NASDAQ:CLVS - Stock Quote & News ...
View recent trades and share price information for Clovis Oncology Inc USD0. 001. Dividend information for this stock is not available. Data policy - All
Clovis Oncology Inc. (CLVS) Stock Quote | Price Chart ... View a financial market summary for CLVS including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CLVS (Clovis Oncology Inc.) stock.
Clovis Oncology - CLVS - Stock Price & News | The Motley Fool
CLVS Stock Quote - Clovis Oncology, Inc. Stock Price Today Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. Its marketed product Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is offered for the maintenance treatment of adult patients with recurrent epithelial CLVS | Clovis Oncology Inc. Stock Price & News - WSJ View the latest Clovis Oncology Inc. (CLVS) stock price, news, historical charts, analyst ratings and financial information from WSJ.
CLVS | Complete Clovis Oncology Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview.
In recent Clovis Oncology news, CLVS stock is down close to 12% as the company's stopped its trial to treat bladder cancer, a report says.
Clovis Oncology. CLVS. CLVS. Clovis Oncology Stock Quote. $6.79 -$0.01 Clovis Oncology, Inc. Common Stock (CLVS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Stock analysis for Clovis Oncology Inc (CLVS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Prev Close 6.10, 52 Wk Low 2.93. Open 6.36, 52 Wk High 25.88. Day Low 6.04, Volume 5.8M. Day High 6.98, Avg 10D Vol 8.3M CLVS: Get the latest Clovis Oncology stock price and detailed information including CLVS news, historical charts and realtime prices.